Moreover, the significant downregulation of COX-2 activity observed in the RES-PNPs group suggests direct inhibition of prostaglandin synthesis and attenuation of NF-κB signaling pathways, in accordance with established mechanisms of resveratrol in cancer prevention [46,47,48]. The gene discussed is PTGS2; the disease is cancer.